We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Protocol for the administration of COVID-19 mRNA vaccine to individuals aged 5 years and over in accordance with the national COVID-19 vaccination programme.
Guidance for healthcare practitioners about the coronavirus (COVID-19) vaccination programme.
Information on the third and booster doses for people with a weakened immune system.
Information about the common side effects of vaccinations that might occur in babies and young children up to 5 years of age.
Respiratory syncytial virus immunisation information for public health professionals, including updates.
Hepatitis A immunisation information for public health professionals.
Measles immunisation information for public health professionals, including updates.
Varicella immunisation information for public health professionals, including updates.
PGD template for Shingrix® vaccine for immunocompromised individuals.
Public health principles for reducing the spread of respiratory infections, including COVID-19, in the workplace.
Guidance for living safely with respiratory infections, including coronavirus (COVID-19).
A to Z list of countries and their category of risk for rabies.
Information about the meningococcal B (MenB) vaccine and paracetamol use.
Knowledge and skills competence assessment tool.
Information for public health professionals on immunisation.
Patient Group Direction (PGD) template to support the national vaccination programme for pregnant women to protect infants and older adults aged 75 to 79 years old.
How to manage cases of suspected measles: what patient details to take, who to notify and assessing risk of disease spreading in close contacts.
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).